These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 23050328)

  • 1. Stability of omeprazole in SyrSpend SF Alka (reconstituted).
    Whaley PA; Voudrie MA; Sorenson B
    Int J Pharm Compd; 2012; 16(2):164-6. PubMed ID: 23050328
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stability of vancomycin in SyrSpend SF.
    Whaley PA; Voudrie MA
    Int J Pharm Compd; 2012; 16(2):167-9. PubMed ID: 23050329
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stability of ursodiol in SyrSpend SF Cherry flavored.
    Geiger CM; Voudrie MA; Sorenson B
    Int J Pharm Compd; 2012; 16(6):510-2. PubMed ID: 23259368
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stability of propranolol hydrochloride in SyrSpend SF.
    Geiger CM; Voudrie MA; Sorenson B
    Int J Pharm Compd; 2012; 16(6):513-5. PubMed ID: 23259369
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stability of midazolam in syrspend SF and syrspend SF cherry.
    Geiger CM; Sorenson B; Whaley PA
    Int J Pharm Compd; 2013; 17(4):344-6. PubMed ID: 24261150
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stability of captopril in SyrSpend SF.
    Geiger CM; Sorenson B; Whaley PA
    Int J Pharm Compd; 2013; 17(4):336-8. PubMed ID: 24261148
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stability of Oseltamivir Phosphate in SyrSpend SF, Cherry Syrup, and SyrSpend SF (For Reconstitution).
    Voudrie Ii MA; Allen DB
    Int J Pharm Compd; 2010; 14(1):82-6. PubMed ID: 23965375
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stability of gabapentin in SyrSpend SF.
    Sorenson B; Voudrie MA; Gehrig D
    Int J Pharm Compd; 2012; 16(4):347-9. PubMed ID: 23050395
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stability Assessment of 10 Active Pharmaceutical Ingredients Compounded in SyrSpend SF.
    Geiger CM; Sorenson B; Whaley P
    Int J Pharm Compd; 2015; 19(5):420-7. PubMed ID: 26775449
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stability of rifampin in SyrSpend SF.
    Sorenson B; Whaley P
    Int J Pharm Compd; 2013; 17(2):162-4. PubMed ID: 23696177
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stability of partial doses of omeprazole-sodium bicarbonate oral suspension.
    Johnson CE; Cober MP; Ludwig JL
    Ann Pharmacother; 2007 Dec; 41(12):1954-61. PubMed ID: 17956960
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stability and viscosity of a flavored omeprazole oral suspension for pediatric use.
    Burnett JE; Balkin ER
    Am J Health Syst Pharm; 2006 Nov; 63(22):2240-7. PubMed ID: 17090745
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stability of Allopurinol, Amitriptyline Hydrochloride, Carbamazepine, Domperidone, Isoniazid, Ketoconazole, Lisinopril, Naproxen, Paracetamol (Acetaminophen), and Sertraline Hydrochloride in SyrSpend SF PH4 Oral Suspensions.
    Polonini HC; Loures S; de Araujo EP; Brandão MA; Ferreira AO
    Int J Pharm Compd; 2016; 20(5):426-434. PubMed ID: 28339378
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Effect of Manufacturer on the Compounding of Omeprazole Suspensions and Their Stability Assessment.
    Meissner S; Bansal M; Dela CPD; Hanning S; Svirskis D
    Int J Pharm Compd; 2020; 24(2):140-147. PubMed ID: 32196476
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Compatibility of cholecalciferol, haloperidol, imipramine hydrochloride, levodopa/carbidopa, lorazepam, minocycline hydrochloride, tacrolimus monohydrate, terbinafine, tramadol hydrochloride and valsartan in SyrSpend SF PH4 oral suspensions.
    Polonini HC; Silva SL; Cunha CN; Brandão MA; Ferreira AO
    Pharmazie; 2016 Apr; 71(4):185-91. PubMed ID: 27209697
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Compatibility of proton pump inhibitors in a preservative-free suspending vehicle.
    Polonini HC; Silva SL; Loures S; Almy R; Balland A; Brandão MAF; Ferreira AO
    Eur J Hosp Pharm; 2018 May; 25(3):150-156. PubMed ID: 31157010
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stability of Metronidazole Benzoate in SyrSpend SF One-Step Suspension System.
    Vu NT; Aloumanis V; Ben M; Kupiec TC; Patterson EK; Radke J; Erickson Iii MA; Schneider G
    Int J Pharm Compd; 2008; 12(6):558-64. PubMed ID: 23969934
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stability of Acetazolamide, Baclofen, Dipyridamole, Mebeverine Hydrochloride, Propylthiouracil, Quinidine Sulfate, and Topiramate Oral Suspensions in SyrSpend SF PH4.
    Ferreira AO; Polonini H; da Silva SL; Aglio NCB; Abreu J; Fernandes BMA
    Int J Pharm Compd; 2017; 21(4):339-346. PubMed ID: 28719377
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stability of Azathioprine, Clonidine Hydrochloride, Clopidogrel Bisulfate, Ethambutol Hydrochloride, Griseofulvin, Hydralazine Hydrochloride, Nitrofurantoin, and Thioguanine Oral Suspensions Compounded with SyrSpend SF pH4.
    Polonini H; da Silva SL; Cunha CN; Ferreira AO; Anagnostou K; Dijkers E
    Int J Pharm Compd; 2020; 24(3):252-262. PubMed ID: 32401746
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stability of minoxidil in Espumil foam base.
    Geiger CM; Sorenson B; Whaley PA
    Int J Pharm Compd; 2013; 17(2):165-7. PubMed ID: 23696178
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.